12-29-4　ⓔ文献

  1. 日本膵臓学会・厚生労働科学研究費補助金 (難治性疾患等政策研究事業) 「IgG4 関連疾患の診断基準並びに治療指針の確立を目指す研究」班：自己免疫性膵炎臨床診断基準 2018 (自己免疫性膵炎臨床診断基準 2011 改訂版)．膵臓，2018; 33: 902–913.

  2. Hart PA, Kamisawa T, et al: Long–term outcomes of autoimmune pancreatitis: a multicentre international analysis. Gut, 2013; 62: 1771–1776.

  3. Uchida K, Okazaki K: Clinical and pathophysiological aspects of type 1 autoimmune pancreatitis. J Gastroenterol, 2018; 53: 475–485.

  4. Kawaguchi K, Koike M, et al: Lymphoplasmacytic sclerosing pancreatitis with cholangitis: A variant primary sclerosing cholangitis extensively involving pancreas. Hum Pahtol, 1991; 22: 387.

  5. Zamboni G, Luttges J, et al: Histopathological features of diagnostic and clinical relevance in autoimmune pancreatitis: a study on 53 resection specimens and 9 biopsy specimens. Virchows Arch, 2004; 445: 552.

  6. Masamune A, Kikuta K, et al: Nationwide epidemiological survey of autoimmune pancreatitis in Japan in 2016. J Gastroenterol, 2020; 55: 462–470.

  7. Nishimori I, Tamakoshi A, et al: Research Committee on Intractable Diseases of the Pancreas, Ministry of Health, Labour, and Welfare of Japan. Prevalence of autoimmune pancreatitis in Japan from a nationwide survey in 2002. J Gastroenterol, 2007; 42 (suppl 18): 6–8.

  8. Notohara K, Burgart LJ, et al: Idiopathic chronic pancreatitis with periductal lymphoplasmacytic infiltration: clinicopathologic features of 35 cases. Am J Surg Pathol, 2003; 27: 1119–1127.

  9. 日本膵臓学会・厚生労働省IgG4関連疾患の診断基準並びに治療指針を目指す研究班：自己免疫性膵炎診療ガイドライン2020．膵臓，2020; 35: 465–550.

  10. Takuma K, Kamisawa T, et al: Short–term and long–term outcomes of autoimmune pancreatitis. Eur J Gastroenterol Hepatol, 2011; 23: 146–152.

  11. Uchida K, Yazumi S, et al: Long–term outcome of autoimmune pancreatitis. J Gastroenterol, 2009; 44: 726–732.

  12. Maruyama M, Arakura N, et al: Type 1 autoimmune pancreatitis can transform into chronic pancreatitis: a long–term follow–up study of 73 Japanese patients. Int J Rheumatol, 2013; 272595.

  13. Maruyama M, Watanabe T, et al: Autoimmune pancreatitis can develop into chronic pancreatitis. Orphanet J Rare Dis, 2014; 9: 77.

  14. Ikeura T, Miyoshi H, et al: Relationship between autoimmune pancreatitis and pancreatic cancer: a single–center experience. Pancreatology, 2014; 14: 373–379.

  15. Shiokawa M, Kodama Y, et al: Risk of cancer in patients with autoimmune pancreatitis. Am J Gastroenterol, 2013; 108: 610–617.

  16. Yamamoto M, Takahashi H, et al: Risk of malignancies in IgG4–related disease. Mod Rheumatol, 2012; 22: 414–418.

  17. Masamune A, Nishimori I, et al: Randomised controlled trial of long–term maintenance corticosteroid therapy in patients with autoimmune pancreatitis. Gut, 2017; 66: 487–494.

  18. Hart PA, Topazian MD, et al: Treatment of relapsing autoimmune pancreatitis with immunomodulators and rituximab: the Mayo Clinic experience. Gut, 2013; 62: 1607–1615.